Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jun-Jie Li
Observed names:
Junjie Li,
Jun‐Jie Li
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
ORCID:
0009-0006-9761-0121
Observed ORCID:
0009-0006-9761-0121
OpenAlex ID:
A5121064840
Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial
2025
·
Yin Liu
, Yue Gong
, et al.
·
BMJ
·
15
PDF
CD8-guided immunochemotherapy improves pathological complete response rates in high-tumor-burden triple-negative breast cancer
2025
·
Li Chen
, Shu-hao Jiang
, et al.
·
Molecular Therapy
·
4
Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2−breast cancer: A randomized, phase 2 trial FASCINATE-N
2026
·
Jun-Jie Li
, Lin-Xiaoxi Ma
, et al.
·
Cell Reports Medicine
·
1
Integrated genomic profiling identifies predictive biomarkers for neoadjuvant therapy response in Chinese breast cancer patients
2026
·
Xiao-Han Ying
, Kun-Yu Zhang
, et al.
·
Cancer Letters
·
1
Omission of Axillary Surgery in Patients with Negative Axillary Evaluation Integrated with LymphPET: A Prospective Clinical Study
2026
·
Fei-Lin Qu
, Jing-Yi Cheng
, et al.
·
Annals of Surgical Oncology
·
1
CHST1 Drives Immunotherapy Resistance in Triple‐Negative Breast Cancer by Orchestrating an Immunosuppressive Microenvironment via the NKRF–CCL20–Macrophage Axis
2026
·
Shu‐Hao Jiang
, Xiao‐Han Ying
, et al.
·
Advanced Science
The conditional promise of dual-epitope HER2 antibody-drug conjugates in breast cancer
2026
·
Ruoqing Wang
, Shuhao Jiang
, et al.
·
Cancer Biology and Medicine
ASO Visual Abstract: Omission of Axillary Surgery in Patients with Negative Axillary Evaluation Integrated with LymphPET: A Prospective Clinical Study
2026
·
Fei-Lin Qu
, Jing-Yi Cheng
, et al.
·
Annals of Surgical Oncology
ASO Author Reflections: Visions in Axilla Management with Clinical Advances in LymphPET for Breast Cancer
2026
·
Fei-Lin Qu
, Jing-Yi Cheng
, et al.
·
Annals of Surgical Oncology
Show more works
View as search
Works count:
9
Citation count:
22
H-index:
2
I10-index:
1
Year
Topic
Type